Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia
2021 · Cancer Discovery · 70 citations
https://doi.org/10.1158/2159-8290.cd-20-0738
A
Andrea Newbold
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
2.1K
Citations
20
h-index
26
i10-index
Andrea Newbold is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Cytokine Signaling Pathways and Interactions & Mathematical Biology Tumor Growth. The author has an h-index of 20, co-authored 73 publications.
ORCID: 0000-0002-0481-2431Papers by this author
worksTherapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells
2016 · Cell Reports · 40 citations
https://doi.org/10.1016/j.celrep.2016.01.059
Induction of autophagy does not alter the anti-tumor effects of HDAC inhibitors
2012 · Cell Death and Disease · 10 citations
https://doi.org/10.1038/cddis.2012.128
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat